Tocilizumab Dosing in Juvenile Idiopathic Arthritis: Optimizing for Different Juvenile Idiopathic Arthritis Type and Patient Body Weight

被引：0
|
作者：
Lu, Peng [1 ]
Hsu, Joy [1 ]
Keane, Caroline [2 ]
Fettner, Scott [1 ]
Wang, Jianmei [2 ]
Ruperto, Nicolino [3 ]
Harari, Olivier [2 ]
Brunner, Hermine [4 ]
De Benedetti, Fabrizio [5 ]
机构：
[1] Roche, Nutley, NJ USA
[2] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[3] PRINTO, Genoa, Italy
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[5] IRCCS Osped Pediat Bambino Gesu, Rome, Italy
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
10.1002/art.38597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A171
引用
收藏
页码：S222 / S223
页数：2
相关论文
共 50 条
  • [1] Tocilizumab for rheumatoid and juvenile idiopathic arthritis
    Bongartz, Tim
    [J]. LANCET, 2008, 371 (9617): : 961 - 963
  • [2] Tocilizumab for the Treatment of Juvenile Idiopathic Arthritis
    Decelle, Kendra
    Horton, Evan R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 822 - 829
  • [3] Tocilizumab for Systemic Juvenile Idiopathic Arthritis
    Hagino, Noboru
    Yamaguchi, Ken-ichi
    Ohara, Yuri
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (13): : 1256 - 1256
  • [4] Tocilizumab for treating juvenile idiopathic arthritis
    Turnier, Jessica L.
    Brunner, Hermine I.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (04) : 559 - 566
  • [5] PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
    P Lu
    J Hsu
    C Keane
    S Fettner
    J Wang
    N Ruperto
    O Harari
    HI Brunner
    F De Benedetti
    [J]. Pediatric Rheumatology, 11 (Suppl 2)
  • [6] Tocilizumab for the treatment of systemic juvenile idiopathic arthritis
    Herlin, Troels
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (06) : 517 - 525
  • [7] Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
    Murakami, Miho
    Tomiita, Minako
    Nishimoto, Norihiro
    [J]. OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2012, 4 : 71 - 79
  • [8] Guidance on using tocilizumab for juvenile idiopathic arthritis
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Takei, Syuji
    Murata, Takuji
    Tomiita, Minako
    Itoh, Yasuhiko
    Fujikawa, Satoshi
    Mori, Masaaki
    [J]. MODERN RHEUMATOLOGY, 2011, 21 (06) : 563 - 571
  • [9] Safety of tocilizumab in the treatment of juvenile idiopathic arthritis
    Machado, Sandra Helena
    Xavier, Ricardo Machado
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 493 - 500
  • [10] Arthritis Mutilans in a Patient with Juvenile Idiopathic Arthritis
    Nakamura, Jun
    Nagashima, Takao
    Yoshio, Taku
    Minota, Seiji
    [J]. INTERNAL MEDICINE, 2015, 54 (06) : 689 - 689
12345